Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation operates as a non-profit organization that focuses on healthcare, poverty, and educational sectors in developing countries.

Company Overview

The organization provides grants for agricultural development, global health, and technical education programs. Bill & Melinda Gates Foundation was formerly known as William H. Gates Foundation and changed its name in 2000. The organization was founded in 1994 and is headquartered in Seattle, Washington.


The Bill & Melinda Gates Foundation is a grant-making foundation that supports initiatives in education, world health and population, and community giving in the Pacific Northwest. In its local region, the foundation promotes strategies and programs that help low-income families. The Bill & Melinda Gates Foundation was co-founded by Bill Gates and Melinda Gates in 2000 and is based in Seattle, Washington, with regional offices in Washington, D.C.; New Delhi, India; Beijing, China; and London, United Kingdom. Its trustees are Bill and Melinda Gates, and Warren Buffett.

The Bill & Melinda Gates Foundation is a partner of the Global Fund, provides cash contributions, participates on its board and committees, and supports the Global Fund's advocacy, communications and fundraising efforts.

The Gates Foundation has contributed US$2 billion to the Global Fund as of January 2018, and pledged US$600 million for the Global Fund's Fifth Replenishment, covering 2017-2019. This includes US$132 million in matching funds with the United Kingdom's private sector malaria matching challenge, and up to US$100 million to unlock other private sector contributions, including funds that go through (RED). The Gates Foundation and other foundations are represented on the Global Fund Board through the private foundations delegation.

The main mission of the foundation is to make advances in:.

  • Discover new insights to fight diseases and other health problems affecting developing countries.
  • Develop effective and affordable vaccines, medicines, and other health tools.
  • Deliver health solutions.

The foundation's Global Health Program that accounts for about 50 percent of total spending focuses on 20 diseases. The top five are: diarrheal diseases (including rotavirus), pneumonia, malaria--most deadly to kids--and AIDS and TB, which mostly affect adults.

The Bill & Melinda Gates Foundation supports advocacy efforts to build awareness of global health challenges, develop new ways to finance health programs, and improve health data.


Bill & Melinda Gates Foundation has made 93 investments. One such investment was on Jan 29, 2019, when they invested $55M in Lyndra Therapeutics. Bill & Melinda Gates Foundation has had 14 exits which include Novartis, Moderna Therapeutics, and Synlogic. Bill & Melinda Gates Foundation has $43M in revenue annually and it competes with Carnegie Corporation of New York, Open Society Foundations, and Lumina Impact Ventures.

The Gates Foundation has funded many of the Friends of the Global Fund organizations as well as advocacy partners in both developing and developed countries. The foundation provided support to develop and launch initiatives like Debt2Health and (PRODUCT)RED. The foundation has also funded special initiatives in the health supply chain related to the Global Fund.


February 2020

The Bill & Melinda Gates Foundation commits up to $100 million to help fight against the Corona virus.

September 17, 2019

The Bill & Melinda Gates Foundation launches its third annual Goalkeepers Data Report.

January 2018

The Gates Foundation has contributed US$2 billion to the Global Fund as of January 2018, and pledged US$600 million for the Global Fund's Fifth Replenishment, covering 2017-2019.

Funded Companies


A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.

A medical company in Massachusetts focusing on lowering the cost of vaccine distribution.

A biotechnology company that develops medicines based on live bacterial consortia that can colonize the human intestine.

Clinical stage biotechnology company focused on treating infectious diseases using recombinant nanoparticle vaccine technology

Butterfly Network is a company developing and designing a medical imaging device for real-time and three-dimensional or 3D imaging and treatment.

Evolve Biosystems is a company developing a consumer product, Evivo, that improves infants' gut health.

Masimo is an Irvine, California-based biosensor company founded in 1989 by Joe Kiani.

A biopharmecutical company developing human antibody based therapies

BetterLesson is a Cambridge, Massachusetts-based company.

A company developing targeted monoclonal antibody immunotherapies for the treatment of infectious diseases

Affinivax is a Cambridge, Massachusetts-based company founded in 2014 by Richard Malley, MD, Fan Zhang, PhD, Yingjie Lu, PhD and Kamran Tavangar.

A company developing diagnostic platforms such as test for HIV/AIDS and cell counting

Atomo Diagnostics is a Leichhardt, New South Wales-based designer and manufacturer of blood-based medical diagnostic and test devices.

CropIn Technology Solutions is an India-based business analytics company founded by CropIn Technology.

Lyndra Therapeutics is a Watertown, Massachusetts-based company.

PnuVax is a Kingston, Ontario-based company founded in 2011 by Dr. Donald Gerson, Jonas Elliott Gerson and Allison Turner.

Stellapps is an India-based company.

Immunethep is a Coimbra-based company founded in 2013.

22 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine



Further reading


Documentaries, videos and podcasts





Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.